Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease leukemia
Phenotype C0023470|myelogenous leukemia
Sentences 4
PubMedID- 23738923 Objective: molecular monitoring using quantitative polymerase chain reaction (qpcr) of bcr-abl mrna transcripts using the international scale (is) is recommended by the national comprehensive cancer network and the european leukemianet for patients with chronic myelogenous leukemia in chronic phase (cml-cp).
PubMedID- 21302443 Objective: to study the proliferative inhibition effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with ph(+), chronic myelogenous leukemia cell line k562 expressing p210 protein and acute lymphoblastic leukemia cell line sup-b15 expressing p190 protein.
PubMedID- 24152491 Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia.
PubMedID- 20184209 leukemia cutis in a patient with acute myelogenous leukemia: a case report and review of the literature.

Page: 1